SCHEMBL7426892

SCHEMBL7426892

O=C1c2ccccc2C(=O)N1CC1CN2CCN1CC2

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ACHE P22303 1/20 0.41
CYP1B1 Q16678 3/20 0.40
ALDH1A1 P00352 2/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
GAA P10253 1/20 0.40
RPS6KA2 Q15349 1/20 0.40
HTR1A P08908 1/20 0.39
HTR7 P34969 1/20 0.39
HRH1 P35367 1/20 0.39
DRD3 P35462 1/20 0.39
HTR2B P41595 1/20 0.39
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
GLS O94925 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15672109 0.70 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19ACHECYP1B1
SCHEMBL1581709 0.70 CYP1B1 (0.59) CYP1A2CYP2C9CYP2C19ACHECYP1B1
SCHEMBL4743617 0.70 CYP1A2 (0.53) CYP1A2CYP2C9CYP2C19ACHEALDH1A1
SCHEMBL28665643 0.68 KMT2A (0.45) ALDH1A1TSHRMAPK1GAACA12
SCHEMBL6736199 0.67 ADRA1D (0.52) ACHE
SCHEMBL11571330 0.67 ALDH1A1 (0.51) CYP1A2CYP2C9CYP2C19ACHEALDH1A1
SCHEMBL38819 0.67 CYP2C9 (0.68) CYP1A2CYP2C9CYP2C19ACHEALDH1A1
SCHEMBL29567211 0.67 CYP2C9 (0.68) CYP1A2CYP2C9CYP2C19ACHEALDH1A1
SCHEMBL78821 0.67 CYP2C9 (0.68) CYP1A2CYP2C9CYP2C19ACHEALDH1A1
SCHEMBL21862658 0.67 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19ACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663173-A CENTRAL NERVOUS SYSTEM DISORDERS, COGNITION ACTIVATORS, PYCHOSES, ANTIDEPRESSANTS AND EATING DISORDERS SYNTHELABO (FR) 1997-09-02 US disclosed
EP-0748807-A1 Derivatives of N-(1,4-diazabicyclo(2.2.2)-oct-2-yl)methyl benzamide, their preparation and their therapeutical use SYNTHELABO (FR) 1996-12-18 EP disclosed